Gerald Harris
Addiction Medicine · Peoria, AZNPI 1689676165
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 229 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 31 manufacturers, the largest accounting for just 16.6% — the pattern of someone who eats at a lot of different presentations.
Across 229 payments — averaging $22.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$836
- Indivior Inc.$472
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$439
- Medtronic$433
- MDD US Operations, LLC$325
- Orexo US, Inc.$321
- plus $2K from 25 others
What the payments were for
- Food & beverage$5,044100%
- Education$10%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 29 | $836 |
| Indivior Inc. | 20 | $472 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 19 | $439 |
| Medtronic(2 entities) | 8 | $433 |
| MDD US Operations, LLC | 26 | $325 |
| Orexo US, Inc. | 24 | $321 |
| Antares Pharma, Inc. | 32 | $317 |
| AbbVie(2 entities) | 9 | $314 |
| Lucid Diagnostics Inc. | 8 | $300 |
| Novo Nordisk | 9 | $246 |
| Lilly USA, LLC | 7 | $204 |
| Spinal Simplicity, LLC | 1 | $136 |
| USWM, LLC | 7 | $118 |
| Pfizer | 6 | $94 |
| Covidien LP | 1 | $87 |
| Bardy Diagnostics, Inc. | 4 | $81 |
| Abbott | 3 | $72 |
| Teva Pharmaceuticals USA, Inc. | 3 | $42 |
| Daiichi Sankyo Inc. | 1 | $25 |
| Alkermes, Inc. | 1 | $19 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $18 |
| Esperion Therapeutics, Inc. | 1 | $18 |
| Titan Pharmaceuticals, Inc. | 1 | $18 |
| Eisai Inc. | 1 | $17 |
| Alfasigma USA, Inc. | 1 | $16 |
| Sanofi-aventis U.S. LLC | 1 | $14 |
| Boston Scientific | 1 | $13 |
| Amgen | 1 | $13 |
| Merck | 1 | $13 |
| Biodelivery Sciences International, Inc. | 1 | $12 |
| Acerus Pharmaceuticals Corporation | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MINIMED 770G$322
- FARXIGA$219
- HA MINUTEMAN G3-R$136
- UBRELVY$124
- Ozempic$122
- SUBLOCADE$121
- TRULANCE$121
- XIFAXAN$108
How this compares
$5,045 in reported general payments places this provider in the 85th percentile of 37 addiction medicine providers in Arizona.
Other addiction medicine in Peoria
- Charles BrookerPeoria$629
- Wen Hui CaiTucson$111K
- Wendell PhillipsPhoenix$16K
- Steven LocnikarScottsdale$7K
- Rosekamal McKinneyGlendale$5K
- J Carvel JacksonMesa$3K
- Scott HavensPhoenix$3K
- Robert HalliganPhoenix$1K
- Michael CarltonPhoenix$918
- Ehab AbdallahScottsdale$865
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.